{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T14:00:52Z","timestamp":1785074452656,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bcp.2026.118181","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T22:19:48Z","timestamp":1781993988000},"page":"118181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["BLM as a potential therapeutic target in cutaneous malignant melanoma"],"prefix":"10.1016","volume":"251","author":[{"given":"Lidan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6975-2306","authenticated-orcid":false,"given":"Yu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118181_b0005","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.3390\/cancers16122262","article-title":"Malignant melanoma: an overview, new perspectives, and vitamin D signaling","volume":"16","author":"Slominski","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2026.118181_b0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/cancers16020470","article-title":"Mechanisms of melanoma progression and treatment resistance: role of cancer stem-like cells","volume":"16","author":"Al Hmada","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2026.118181_b0015","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2026.118181_b0020","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","article-title":"Melanoma","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2026.118181_b0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jid.2020.03.943","article-title":"Treatment of advanced melanoma in 2020 and beyond","volume":"141","author":"Jenkins","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bcp.2026.118181_b0030","first-page":"497","article-title":"The systemic treatment of melanoma","volume":"116","author":"Terheyden","year":"2019","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.bcp.2026.118181_b0035","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1056\/NEJMoa1904059","article-title":"Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma","volume":"381","author":"Robert","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118181_b0040","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118181_b0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s43556-024-00182-2","article-title":"Heterogeneity and molecular landscape of melanoma: implications for targeted therapy","volume":"5","author":"Beigi","year":"2024","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.bcp.2026.118181_b0050","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","article-title":"DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transd. Target. Ther."},{"key":"10.1016\/j.bcp.2026.118181_b0055","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Sci (N. Y. N.Y.)"},{"key":"10.1016\/j.bcp.2026.118181_b0060","unstructured":"Human RecQ helicases in DNA repair, recombination, and replication - PubMed, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/24606147\/ (accessed December 15, 2025)."},{"key":"10.1016\/j.bcp.2026.118181_b0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000452082","article-title":"Bloom\u2019s syndrome: clinical spectrum, molecular pathogenesis, and cancer predisposition","volume":"8","author":"Cunniff","year":"2017","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.bcp.2026.118181_b0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.arr.2017.11.003","article-title":"Werner syndrome (WRN) gene variants and their association with altered function and age-associated diseases","volume":"41","author":"Lebel","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bcp.2026.118181_b0075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/jmg.2005.031781","article-title":"Revisiting the craniosynostosis-radial ray hypoplasia association: baller-gerold syndrome caused by mutations in the RECQL4 gene","volume":"43","author":"Van Maldergem","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bcp.2026.118181_b0080","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/cge.14125","article-title":"Phenotypic spectrum of BLM- and RMI1-related Bloom syndrome","volume":"101","author":"G\u00f6nenc","year":"2022","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bcp.2026.118181_b0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11033-025-10247-2","article-title":"BLM knockdown promotes cells autophagy via p53-AMPK-mTOR pathway in triple negative breast cancer cells","volume":"52","author":"Wang","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bcp.2026.118181_b0090","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00535-016-1222-0","article-title":"Aberrant BLM cytoplasmic expression associates with DNA damage stress and hypersensitivity to DNA-damaging agents in colorectal cancer","volume":"52","author":"Votino","year":"2017","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bcp.2026.118181_b0095","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1073\/pnas.1006423108","article-title":"Inhibition of helicase activity by a small molecule impairs werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress","volume":"108","author":"Aggarwal","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2026.118181_b0100","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1039\/C6OB00936K","article-title":"Modern advances in heterocyclic chemistry in drug discovery","volume":"14","author":"Taylor","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bcp.2026.118181_b0105","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.annonc.2025.03.023","article-title":"PALMARES-2 Study Group, Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive\/HER2-negative BC patients: results from the multicenter PALMARES-2 study","volume":"36","author":"Provenzano","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bcp.2026.118181_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105669","article-title":"Synthesis and biological evaluation of 6-(pyrimidin-4-yl)-1H-pyrazolo[4,3-b]pyridine derivatives as novel dual FLT3\/CDK4 inhibitors","volume":"121","author":"Li","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bcp.2026.118181_b0115","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrm.2017.67","article-title":"The essential kinase ATR: ensuring faithful duplication of a challenging genome","volume":"18","author":"Saldivar","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118181_b0120","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2026.118181_b0125","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3390\/cells14100748","article-title":"Cancer vulnerabilities through targeting the ATR\/Chk1 and ATM\/Chk2 axes in the context of DNA damage","volume":"14","author":"Fernandez","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118181_b0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-380888-2.00003-0","article-title":"The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer","volume":"108","author":"Smith","year":"2010","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118181_b0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-E","article-title":"GROMACS: a message-passing parallel molecular dynamics implementation","volume":"91","author":"Berendsen","year":"1995","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.bcp.2026.118181_b0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0009-2614(01)00393-1","article-title":"Particle mesh ewald method for three-dimensional systems with two-dimensional periodicity","volume":"340","author":"Kawata","year":"2001","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.bcp.2026.118181_b0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.physleta.2005.04.046","article-title":"A parrinello\u2013rahman approach to vortex lattices","volume":"341","author":"Carretero-Gonz\u00e1lez","year":"2005","journal-title":"Phys. Lett. A"},{"key":"10.1016\/j.bcp.2026.118181_b0150","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bcp.2026.118181_b0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4939-2269-7_22","article-title":"Drug affinity responsive target stability (DARTS) for small molecule target identification","volume":"1263","author":"Pai","year":"2015","journal-title":"Methods Mol. Biol. (Clifton N.J.)"},{"key":"10.1016\/j.bcp.2026.118181_b0160","first-page":"1881","article-title":"An overview of RecQ helicases and related diseases","volume":"17","author":"Yiu","year":"2025","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bcp.2026.118181_b0165","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1007\/s00018-013-1325-1","article-title":"The BLM dissolvasome in DNA replication and repair","volume":"70","author":"Manthei","year":"2013","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"key":"10.1016\/j.bcp.2026.118181_b0170","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1083\/jcb.201703144","article-title":"BLM helicase regulates DNA repair by counteracting RAD51 loading at DNA double-strand break sites","volume":"216","author":"Patel","year":"2017","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118181_b0175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.20892\/j.issn.2095-3941.2020.0105","article-title":"RECQL4 regulates DNA damage response and redox homeostasis in esophageal cancer","volume":"18","author":"Lyu","year":"2021","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bcp.2026.118181_b0180","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3390\/genes12121919","article-title":"Role and regulation of the RECQL4 Family during genomic integrity maintenance","volume":"12","author":"Luong","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bcp.2026.118181_b0185","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/annonc\/mdy049","article-title":"Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers","volume":"29","author":"Birkbak","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bcp.2026.118181_b0190","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161941","article-title":"Small molecules that disrupt RAD54-BLM interaction hamper tumor proliferation in colon cancer chemoresistance models","volume":"134","author":"Kaur","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118181_b0195","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1002\/1878-0261.13224","article-title":"Resistance to DNA repair inhibitors in cancer","volume":"16","author":"Baxter","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bcp.2026.118181_b0200","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2022-SY39-01","article-title":"Abstract SY39-01: the DNA damageome and cancer evolution","volume":"82","author":"Rosenberg","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118181_b0205","doi-asserted-by":"crossref","first-page":"15907","DOI":"10.3390\/ijms242115907","article-title":"Targeting the DNA damage response for cancer therapy","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118181_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.842496","article-title":"Melanoma, melanin, and melanogenesis: the Yin and Yang relationship","volume":"12","author":"Slominski","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.bcp.2026.118181_b0215","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.abb.2014.06.030","article-title":"The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1\u03b1 expression and HIF-dependent attendant pathways","volume":"563","author":"Slominski","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2026.118181_b0220","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","article-title":"Melanin pigmentation in mammalian skin and its hormonal regulation","volume":"84","author":"Slominski","year":"2004","journal-title":"Physiol. Rev."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:18:35Z","timestamp":1785071915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226005204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"alternative-id":["S0006295226005204"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118181","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BLM as a potential therapeutic target in cutaneous malignant melanoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118181"}}